Our top pick for
Fathom Holdings Inc is a real estate services business based in the US. Fathom shares (FTHM) are listed on the NASDAQ and all prices are listed in US Dollars. Fathom employs 38 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$24.66|
|52-week range||$17.93 - $56.81|
|50-day moving average||$27.21|
|200-day moving average||$30.23|
|Wall St. target price||$54.25|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.52|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-14)||4.71%|
|1 month (2021-09-21)||-11.96%|
|3 months (2021-07-21)||-11.87%|
|6 months (2021-04-21)||-22.67%|
|1 year (2020-10-21)||30.61%|
|2 years (2019-10-17)||N/A|
|3 years (2018-10-17)||N/A|
|5 years (2016-10-17)||N/A|
|Revenue TTM||$243.1 million|
|Gross profit TTM||$10.4 million|
|Return on assets TTM||-11.85%|
|Return on equity TTM||-27.33%|
|Market capitalisation||$363.8 million|
TTM: trailing 12 months
There are currently 837,576 Fathom shares held short by investors – that's known as Fathom's "short interest". This figure is 0.8% down from 844,631 last month.
There are a few different ways that this level of interest in shorting Fathom shares can be evaluated.
Fathom's "short interest ratio" (SIR) is the quantity of Fathom shares currently shorted divided by the average quantity of Fathom shares traded daily (recently around 23640.304826418). Fathom's SIR currently stands at 35.43. In other words for every 100,000 Fathom shares traded daily on the market, roughly 35430 shares are currently held short.
However Fathom's short interest can also be evaluated against the total number of Fathom shares, or, against the total number of tradable Fathom shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Fathom's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Fathom shares in existence, roughly 60 shares are currently held short) or 0.1467% of the tradable shares (for every 100,000 tradable Fathom shares, roughly 147 shares are currently held short).
A SIR above 20% would generally be considered very high, pointing to a pessimistic outlook for the share price, with a discouraging number of investors currently willing to bet against Fathom.
Find out more about how you can short Fathom stock.
We're not expecting Fathom to pay a dividend over the next 12 months.
Fathom Holdings Inc. provides cloud-based real estate brokerage services in the South, Atlantic, Southwest, and Western parts of the United States. The company offers access to various properties for sale or lease through its Website, www. FathomRealty. com to buyers, sellers, landlords, and tenants. It also operates intelliAgent, a real estate technology platform that is designed to provide a suite of brokerage and agent level tools, technology, business processes, business intelligence and reporting, training, customer relationship management, social media marketing, marketing repository, and marketing services, as well as marketplace for add-on services and third-party technology. Fathom Holdings Inc.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.